NCT00560001

Brief Summary

The objective of this study is to quantify the benefits of using the MD.2 on health outcomes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for phase_3

Timeline
Completed

Started Jan 2006

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

November 15, 2007

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 19, 2007

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2008

Completed
Last Updated

October 8, 2009

Status Verified

November 1, 2007

First QC Date

November 15, 2007

Last Update Submit

October 7, 2009

Conditions

Keywords

frail elderlymedication errorspatient compliance & attitudesguideline adherence

Outcome Measures

Primary Outcomes (1)

  • The rate of hospitalizations and emergency room visits will be compared between the MD.2 and control clients

    per month (30 client days) over 6 consecutive months

Secondary Outcomes (3)

  • Compare the length of time in case management for MD.2 clients to control clients.

    Over 6 consecutive months.

  • Measure changes in caregiver stressors and burden between those with the MD.2 and those with their usual medication routine.

    Over 6 consecutive months

  • Determine if cognitive and functional characteristics influence compliance rates among the frail elderly using the MD.2.

    Over 6 consecutive months

Study Arms (2)

A

EXPERIMENTAL

Those subjects that receive an MD.2 Medication Dispenser

Behavioral: MD.2 Medication Dispenser

B

NO INTERVENTION

Control subjects that do not receive an MD.2 Medication Dispenser, but continue to take their medications utilizing standard care, such as pill boxes, etc.

Behavioral: MD.2 Medication Dispenser

Interventions

For those subjects receiving an MD.2 Medication Dispenser, the machine organizes medications and provides verbal and auditory explicit reminders for individuals to take their medications. At the scheduled time, the patient gets a series of reminders. The patient is then expected to push a single button to dispense a pre-filled medication cup. An automatic record is kept of the subject's medication adherence. Interviewer-administered surveys of the Geriatric Depression Scale, SF-12 Health Status Inventory, self-reported medication compliance and recent hospitalizations and emergency room visits will be given. Caregivers will complete the Caregiver Burden Interview.

AB

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A client must:
  • Be coming up for regular review in Case or Medication Management
  • Require medication management services
  • Have two or more doses of medication per day
  • Have someone to fill MD.2
  • Be in independent living (may be assisted living with NO medication management services)
  • Be expected to live through follow-up period of six months
  • Have an active phone line that can be utilized by the MD.2 system.

You may not qualify if:

  • A client cannot have/or be the following:
  • Have someone available to administer medications for every dose
  • Have someone in household who is likely to interfere with MD.2
  • Blind AND deaf
  • Eligible for hospice
  • An MD.2 currently

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Iowa

Iowa City, Iowa, 52242-1101, United States

RECRUITING

Related Publications (14)

  • Stuck AE, Beers MH, Steiner A, Aronow HU, Rubenstein LZ, Beck JC. Inappropriate medication use in community-residing older persons. Arch Intern Med. 1994 Oct 10;154(19):2195-200.

    PMID: 7944840BACKGROUND
  • Aparasu RR, Mort JR. Inappropriate prescribing for the elderly: beers criteria-based review. Ann Pharmacother. 2000 Mar;34(3):338-46. doi: 10.1345/aph.19006.

    PMID: 10917382BACKGROUND
  • Zhan C, Sangl J, Bierman AS, Miller MR, Friedman B, Wickizer SW, Meyer GS. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA. 2001 Dec 12;286(22):2823-9. doi: 10.1001/jama.286.22.2823.

    PMID: 11735757BACKGROUND
  • Gray SL, Mahoney JE, Blough DK. Adverse drug events in elderly patients receiving home health services following hospital discharge. Ann Pharmacother. 1999 Nov;33(11):1147-53. doi: 10.1345/aph.19036.

    PMID: 10573310BACKGROUND
  • Kimura H. Effects of caffeine on cleavage delay of sea urchin eggs induced by ethidium bromide or puromycin. J Radiat Res. 1975 Jun;16(2):125-31. doi: 10.1269/jrr.16.125. No abstract available.

    PMID: 1171974BACKGROUND
  • Bero LA, Lipton HL, Bird JA. Characterization of geriatric drug-related hospital readmissions. Med Care. 1991 Oct;29(10):989-1003. doi: 10.1097/00005650-199110000-00005.

    PMID: 1921531BACKGROUND
  • Chrischilles EA, Segar ET, Wallace RB. Self-reported adverse drug reactions and related resource use. A study of community-dwelling persons 65 years of age and older. Ann Intern Med. 1992 Oct 15;117(8):634-40. doi: 10.7326/0003-4819-117-8-634.

    PMID: 1530194BACKGROUND
  • Farris KD, Kelly MW, Tryon J. Clock drawing test and medication complexity index as indicators of medication management capacity: a pilot study. J Am Pharm Assoc (Wash). 2003 Jan-Feb;43(1):78-81. No abstract available.

    PMID: 12585756BACKGROUND
  • Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990 Apr;150(4):841-5.

    PMID: 2327844BACKGROUND
  • DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002 Sep;40(9):794-811. doi: 10.1097/00005650-200209000-00009.

    PMID: 12218770BACKGROUND
  • Buckwalter KC, Wakefield BJ, Hanna B, Lehmann J. New technology for medication adherence: electronically managed medication dispensing system. J Gerontol Nurs. 2004 Jul;30(7):5-8. doi: 10.3928/0098-9134-20040701-04. No abstract available.

    PMID: 15287321BACKGROUND
  • Maddigan SL, Farris KB, Keating N, Wiens CA, Johnson JA. Predictors of older adults' capacity for medication management in a self-medication program: a retrospective chart review. J Aging Health. 2003 May;15(2):332-52. doi: 10.1177/0898264303251893.

    PMID: 12795276BACKGROUND
  • Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986 Jan;24(1):67-74. doi: 10.1097/00005650-198601000-00007.

    PMID: 3945130BACKGROUND
  • Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980 Dec;20(6):649-55. doi: 10.1093/geront/20.6.649. No abstract available.

    PMID: 7203086BACKGROUND

MeSH Terms

Conditions

Patient ComplianceBehavior

Condition Hierarchy (Ancestors)

Patient Acceptance of Health CareTreatment Adherence and ComplianceHealth Behavior

Study Officials

  • Karen Farris, Ph.D.

    University of Iowa

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Karen Farris, Ph.D.

CONTACT

Julie Lang, M.S.; M.B.A

CONTACT

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

November 15, 2007

First Posted

November 19, 2007

Study Start

January 1, 2006

Study Completion

May 1, 2008

Last Updated

October 8, 2009

Record last verified: 2007-11

Locations